In support of the U.S. Government’s Project NextGen Initiative, J&J Innovation, together with BARDA, announced today that Centivax has been selected as an awardee of the Blue Knight QuickFire Challenge: Accelerating Project NextGen. jnjinnovation.com/news/press-rel…

We are thrilled to be announced as one of the awardees for the #BLUEKNIGHT #QuickFireChallenge. Looking ahead with great anticipation to continue innovating for a better and safer future.

prnewswire.com/news-releases/…

Jake Glanville from Centivax talking about the importance of next gen influenza vaccines

A deadly strain of bird flu has been detected in dairy cows for the first time. Dr. Jacob Glanville, CEO of biotech firm Centivax, joins "The Daily Report" to explain why this discovery is concerning and how big a risk it poses to public health. cbsnews.com/video/doctor-e…

The Science of Innovation: Jake Glanville on Revolutionizing Biotech and Pandemic Prevention. In this episode ofSync’d Up, host Andreas Dankelmann sits down with Jake Glanville, founder and CEO of Centivax, to discuss his groundbreaking work in biotech. open.spotify.com/episode/44Yxqp…

The Coalition is excited to welcome Blueprint Biosecurity and Centivax as its newest members. Blueprint Biosecurity is a nonprofit dedicated to reducing the threat of airborne disease, and Centivax is a leader in universal vaccine development. Read more here: flucoalition.org/wp-content/upl…

We are honored to join the Coalition to Stop Flu as one of its newest members. Read more here: flucoalition.org/wp-content/upl…

Dr. Glanville discusses "Why we need a broad spectrum influenza vaccine" with Radio New Zealand. #influenza #InfluenzaAwareness #Centivax #vaccine #immunology #publichealth #biotech #researchanddevelopment #scientist #QuadDemic rnz.co.nz/news/top/54225…

"Having a trusted partner to conduct rigorous in vitro development of our batch release potency assay is crucial for the immediate need of initiating clinical trials of our first universal vaccine candidate." -Jacob Glanville, CEO. prnewswire.com/news-releases/…

nytimes.com/2025/05/02/hea…

Dr. Glanville and Tim Friede live on CNN.

the-scientist.com/a-man-who-surv…

Tim Friede and Centivax on the cover of the New York Times.

It is Centivax's mission to accelerate the world’s transition to a post-pathogen humanity. #Centivax #TeamCentivax #CentivaxInnovation #CentivaxScience #PublicHealth #InfectiousDiseases #GlobalHealth #HealthInnovation #PandemicPreparedness #ImmunizationMatters #FluShot

Our director of herpetology, Tim Friede, was on Late Night with Seth Meyers in a segment called “The Kind of Story We Need Right Now.” #Centivax #TeamCentivax #CentivaxInnovation #CentivaxScience #PublicHealth #InfectiousDiseases #GlobalHealth #HealthInnovation

Smash the mutants 🦠 to end the pandemic era for humanity — with a single shot for all flu and then coronaviruses, HIV, herpes, malaria, cancer and more! These scourges have evaded effective vaccines because they continuously mutate their outer epitopes to evade our immune

What if flu vaccines really worked? And I mean *really* worked—to the point that humanity's endemic relationship with influenza became history, not an ongoing global health challenge. What if we could mitigate *all* rapidly mutating pathogens? This is why Jake Glanville